Glycine receptor agonist

Last updated

Glycine receptor agonists are medications that act as agonists of the glycine receptor. They are compounds that bind to and activate the inhibitory glycine receptor (GlyR), a chloride-permeable ligand-gated ion channel that mediates fast synaptic inhibition primarily in the spinal cord and brainstem. [1] The natural neurotransmitter glycine is considered a full agonist with maximal efficacy, producing an open probability exceeding 95% when the receptor is fully occupied. [2] Partial agonists such as taurine and β-alanine produce submaximal responses compared to glycine, with taurine eliciting approximately half the maximum open probability response. [2] Recent research has identified aminomethanesulfonic acid (AMS) as a potent glycine receptor agonist that is structurally intermediate between glycine and taurine, achieving a maximum single-channel open probability of 0.85 at acidic pH conditions where it remains chemically stable. [2] Contemporary research has focused on developing positive allosteric modulators (PAMs) of glycine receptors as potential therapeutic agents for chronic pain conditions, given that enhanced glycinergic inhibition can provide analgesia. [3] The tricyclic sulfonamide compound AM-1488 has emerged as a prototypical glycine receptor PAM that also exhibits direct agonistic activity, with oral administration at 20 mg/kg reducing allodynia in mouse models of neuropathic pain comparable to pregabalin treatment. [4]

Contents

Examples

Agonists

PAMs

See also

References

  1. ↑ Ivica, Nemanja; et_al (16 August 2022). "Aminomethanesulfonic acid illuminates the boundary between full and partial agonists at glycine receptors". eLife. 11 e79148. doi: 10.7554/eLife.79148 . PMC   9462852 . PMID   35975975.
  2. 1 2 3 Ivica, Nemanja; et_al (16 August 2022). "Aminomethanesulfonic acid illuminates the boundary between full and partial agonists at glycine receptors". eLife. 11 e79148. doi: 10.7554/eLife.79148 . PMC   9462852 . PMID   35975975.
  3. ↑ Huang, Xinmin (13 February 2025). "Allosteric modulation and direct activation of glycine receptors by a tricyclic sulfonamide positive allosteric modulator". Scientific Reports. 15: 3028. doi:10.1038/s41598-025-90209-7. PMC   11828983 . PMID   39953280 . Retrieved 26 August 2025.
  4. ↑ Yévenes, Gonzalo E; Zeilhofer, Hanns Ulrich (7 August 2017). "Glycine receptors and glycine transporters: targets for novel analgesics in the treatment of chronic pain". Pharmacology & Therapeutics. 181 (6): 45–69. doi:10.1016/j.biotechadv.2017.07.011. PMID   28782586.



This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.